Imidazonaphthyridines and their use in inducing cytokine biosynthesis

Details for Australian Patent Application No. 2002300984 (hide)

Owner Minnesota Mining and Manufacturing Company

Inventors Rice, Michael J.; Lindstrom, Kyle J.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002300984

Parent 19123

Filing date 4 September 2002

Wipo publication date 20 February 2003

Acceptance publication date 2 December 2004

International Classifications

C07D 471/14 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002300984

12 August 2004 Amendment Made

  The nature of the amendment is: Delete the co-inventor Gerster, John F. and add co-inventor Rice, Michael J.

2 December 2004 Application Accepted

  Published as AU-B-2002300984

7 April 2005 Standard Patent Sealed

10 July 2008 Assignment Registered

  Minnesota Mining and Manufacturing Company The patent has been assigned to Takeda Pharmaceutical Company Limited

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002300985-Imidazonaphthyridines And Their Use In Inducing Cytokine Biosynthesis

2002300983-Azolo Triazines And Pyrimidines